Axon Enterprise (NASDAQ:AXON) Posts Quarterly Earnings Results

Axon Enterprise (NASDAQ:AXON) released its earnings results on Tuesday. The biotechnology company reported $0.89 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.48), Zacks reports. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. Axon Enterprise updated its FY 2025 guidance to EPS and its FY 2025 guidance to EPS.

Axon Enterprise Stock Down 0.6 %

Shares of Axon Enterprise stock traded down $3.08 during midday trading on Tuesday, reaching $496.65. 1,316,624 shares of the company’s stock traded hands, compared to its average volume of 751,552. Axon Enterprise has a 52 week low of $265.32 and a 52 week high of $715.99. The company’s 50 day simple moving average is $616.95 and its 200 day simple moving average is $520.78. The company has a market cap of $37.87 billion, a price-to-earnings ratio of 128.33, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Analyst Upgrades and Downgrades

Several research firms have weighed in on AXON. Robert W. Baird lifted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Needham & Company LLC lifted their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Finally, Northland Securities upped their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $561.31.

Insider Transactions at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jeffrey C. Kunins sold 2,304 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total value of $1,508,636.16. Following the completion of the sale, the insider now directly owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This represents a 1.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 8,711 shares of company stock worth $5,631,561. 5.70% of the stock is owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.